The tetrahydropyridine (THP) ring system has received considerable focus due to its excellent ability to act as a pharmacophore. It is recognized as a major constituent in natural alkaloids. THP derivatives have been reported for a diverse range of biological activities. Recent synthetic works contain syntheses of monosubstituted, disubstituted, trisubstituted, highly functionalized, and condensed structures. In this review, we summarize the recent literature dealing with the bioactive nature of this important heterocycle.
Introduction
Biologically active heterocyclic compounds are abundantly found in nature.
1 Among heterocyclic compounds, pyridine and partially reduced dihydropyridine and tetrahydropyridine (THP) have emerged as excellent templates for various bioactive molecules. 2, 3 Three structural isomers of THP are 1,2,3,6-tetrahydropyridine, 1,2,3,4-tetrahydropyridine, and 3,4,5,6-tetrahydropyridine. Arecoline and betanin III are the two natural biologically active THP compounds containing alkaloid and glycoside, respectively. 4−6 The most famous THP-containing neurotoxin is 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, which causes parkinsonism disease. 7, 8 THP-based droperidole and tazomeline act as drugs used for the treatment of Alzheimer disease and schizophrenia. 9, 10 Various THP derivatives have shown antiinflammatory, 11, 12 antianginal, 13 antimicrobial, 14 antifungal, 15 antioxidant, 16 anticancer, 17 and antihypoxic 18 activities. Recently, THP derivatives have also displayed anti-Alzheimer properties. 19 Pharmacological activities of THPs are influenced greatly by the type and nature of substituents attached. 20−23 The broad spectrum of activities presented by these compounds has attracted the attention of medicinal and organic chemists. Different types of methods have been developed for the synthesis of THPs, such as [4 +2 ] cycloaddition reactions, 24 multicomponent reactions, 25, 26 radical cyclization of Baylis-Hillman adducts, aza-Morita-Baylis-Hillman reactions, and two-component reactions of aldimines and tetrahydropyrandiol. 27−29 THPs are also used in the synthesis of piperidine derivatives.
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In this review, THP derivatives are explored for their different pharmacological activities. Structureactivity relationship studies highlighted the important THP-derived compounds with a significant contribution towards the generation of new lead molecules that can serve as templates for future drug design and development.
Activities of tetrahydropyridine derivatives
The various types of activities presented by THP-derived compounds are summarized in the following sections.
THPs as antibacterial agents
Ethyl 1-(2-chloroacetyl)-4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate and their 4-O-aryl sulfonates ( Figure 1 , compounds 1-6) were synthesized by Aridoss et al. 31 Upon evaluation for antibacterial activity compound 1 (IC 50 = 16 µ g/mL) was found to be the most active against Enterococcus faecium while compound 3 (IC 90 = 16 µ g/mL) showed equal activity against E. faecium, E. faecalis, and Staphylococcus aureus.
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Ethyl 4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate derivatives having various heterocyclic rings at the nitrogen atom via acetyl and propyl linkers also displayed antibacterial activities. Compounds having acetyl linkers were more active than those with propyl linkers. Among these derivatives, an imidazolebearing compound (7) showed more prominent activity (IC 90 = 64 µ g/mL) against pathogenic resistant strains of S. aureus, E. faecium, and E. faecalis as compared to standard drugs linezolid and trovafloxacin. 32 6.50-57.94 µ M) as compared to the standard drug, pyrazinamide (IC 50 = 50.77 µ M). Among this series, compounds 9, 10, and 11 (IC 50 = 6.81 µ M, 6.50 µ M, and 6.61 µ M for 9, 10, and 11, respectively) were found to be most potent. THP derivatives were also converted into pyridine derivatives that exhibited relatively higher activity. 33 Another multicomponent reaction of aromatic aldehydes, arylamines, and β -ketoester in the presence of bismuth nitrate was carried out by Yankin et al. 34 It resulted in the formation of alkyl 4-arylamino-1,2,6-triaryl-1,2,5,6-THPs-3-carboxylates. Compounds 12, 13, 14, and 15 were found to be weakly active antibacterial agents (MIC = 250 µ g/mL against E. coli and S. aureus) as compared to standard antibiotics. 34 Srivastava et al. 35 as well as resistant strains of bacteria. Compound 17 was also found to be potent (MIC = 0.12 µ g/mL against different strains of bacteria) and its activity was comparable to that of ciprofloxacin, gatifloxacin, and sparfloxacin. 35 Similarly, 4,5,6,7-tetrahydrothieno[3,2-c]pyridine substituted oxazolidinones exhibited antibacterial activity against resistant strains of S. aureus and E. faecalis. The most potent compound (18) showed almost equivalent activity (MIC = 0.5-1.0 µ g/mL against S. aureus and 1-2 µ g/mL against E. (Figure 3 ), compound 24 (IC 50 = 24 ± 2 nM), had a trifluoromethyl substituted pyridine ring at position #1 and trifluoromethyl sulfonyl substituted benzene ring attached to the nitrogen of the carboxamide group at position #4. It showed increased penetration into the central nervous system (CNS). 39 Pyrazole derivatives having a para amino sulfonyl or para methyl sulfonyl substituted phenyl group at the nitrogen of position #1 constituted the pharmacophore for COX-2 inhibition. 40 formamide. 49 The THP derivatives prepared by Yoon et al. were evaluated for free radical and nitric oxide generation in C6 glioma cells activated with bacterial endotoxin lipopolysaccharide. Compound 37, the most potent (IC 50 = 80.97 µ M) inhibitor of inducible nitric oxide synthase, contains a tertiary butyl group at position #4 of the aromatic ring. These compounds also inhibited the generation of reactive oxygen species in glioma cells, which indicates their potential to be used in neuroinflammatory diseases. 50 Nakao et al. synthesized pyridyl-pyrrole derivatives and compound 38 having a cyclic aminoalkyl group at the beta position of pyrrole showed excellent antiinflammatory (IC 50 = 1.86 µ M) activity upon evaluation as an inhibitor of lipopolysaccharide-induced production of TNF α . The activity decreased when the THP was saturated to the piperidine ring. This compound also showed prominent in vivo activity (ID 50 = 5.89 mg/kg). Therefore, THP was found to be the optimal substituent at this position. 51 Further modification of THP showed that the alkyl group at the nitrogen of THP and at the alpha carbon produced more active compounds. The introduction of a methyl group and propyl group at the nitrogen of the THP and the methyl group at the alpha position further 57 (LC 50 = 2-4 µ g/mL) were found to be most active in this series. Disubstituted compounds showed more activity than monosubstituted but were also found to be more toxic. was higher compared to the quinoline analogues and α 2A adrenoceptors. 64 4-Substituted phenyl analogues of 4-phenyl-1,2,3,6-tetrahydropyridines showed that different electron-withdrawing and electron-donating substituents attached to the aromatic ring influenced the affinity for 5-HT 1A receptors. The most active compound, 67, showed higher affinity (ki = 1.10 ± 0.16) with the 5-HT 1A receptor and it contains a methyl group at position #3 and position #5 of the phenyl ring. This may be due to the increased electron density due to the methyl group, which increases the interaction with the phenylalanine residue, or increased hydrophobic interaction of the methyl group with the valine residue in receptors of 5-HT 1 .
65 4-Phenyl-1,2,3,6-THP rings exhibited prominent affinity with 5-HT 1A receptors as compared to the 4-phenyl piperazine analogues. The molecular modeling studies of this compound carried out by Dilly et al. showed that the phenyl group has a planar orientation with the THP, due to which this compound has more significant interaction with 5-HT 1A receptors.
One possible reason is the replacement of sp 3 nitrogen with sp 2 carbon, which leads to the planar orientation of the phenyl ring. 
Activity of THP derivatives at muscarinic receptors
Bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives were synthesized by Rajeswaran et al.
using the linker groups alkoxy, thioether, and polyethylene glycol. Compound 68 ( Figure 7 ) having alkoxy linkers exhibited high affinity (K 1 = 0.19 ± 0.004 nM) for the muscarinic receptors and contains eight methylene units.
Compound 69 showed more affinity (K 1 = 0.12 ± 0.057 nM) with muscarinic receptors and it contains a 13-atom polyethylene linker chain. attached to the nitrogen of thiazolidinone moiety. It was also active in reversing scopolamine-induced memory loss. Derivatives presented in this series were also found to be nontoxic because no rat fatalities occurred after 1 week of administration of these drugs. 72 Anagnostaras et al. showed that 1,2,5,6-tetrahydropyridine-3-carboxylic acid ester derivatives had antagonistic activity towards muscarinic acetyl choline receptors. These compounds showed more selectivity for the M-5 receptor and this is important because antagonism at the M-1 receptor leads to cognitive deficit. 73 The most active compound, 74, was produced by the modification of carboxylic ester at position #3. Zheng et al. showed that replacement of the ethylene linker with methylene resulted in decreased affinity for the M-5 receptor. The introduction of an electron-withdrawing or electrondonating group at position #4 of the aromatic ring also decreased the activity. Molecular docking studies showed that the binding affinity of compound 74 with the receptor was Ki for h M-5 = 2.24 µ M. This compound also inhibited (IC 50 = 0.45 nM) oxotremorine-evoked dopamine release from rat striatal slices. 
Antiplasmodial activity of THPs
Misra et al. carried out the synthesis of functionalized THPs by multicomponent reaction. These compounds displayed prominent antiplasmodial activity against the Plasmodium falciparum 3D7 strain. Schizontocidal activity of 100% was observed for most of the derivatives at concentrations of 10 µ g/mL and 5 µ g/mL.
Compound 75 (Figure 8 ) showed 100% schizontocidal activity at 0.09 µ g/mL concentration. Structure-activity relationship studies showed that replacement of methyl ester with ethyl ester decreases the antiplasmodial activity while the replacement of benzene rings at position# 2 and position #6 with thiophene or pyridyl rings , and #29 (compound 76) were found to be important for the activity of these compounds. In addition, it was predicted by these calculations that an electron-donating group should be added to position #16 and electron-withdrawing substituents to position #27 to produce more potent compounds. 
THPs as corticotropin-releasing inhibitors
Nakazato et al. carried out the synthesis of 4-aryl-1,2,3,6-tetrahydropyridino-pyrimidine derivatives as nonpeptide corticotropin-releasing factor inhibitors. Compounds 77 (IC 50 = 22 nM) and 78 (IC 50 = 10 nM) in this series were highly potent and selective inhibitors of the CRF 1 receptor (Figure 9 ). In the phenyl group attached to THP at position #4, 3-F and 3-Cl groups are suitable for optimal activity. Changing the position of these groups or replacement with other groups significantly lowers the activity. When the isopropyl group at the phenyl ring was replaced with methyl, a methoxy group, or a chloro group, the resultant derivative showed less activity. The methyl thio group at position #2 of compound 78 acts as a better substituent for the bromo group of compound 77. The presence of the ethyl group is also important because the replacement of this group with others decreases the affinity for the receptor. Similarly, the modification of the methyl group also decreases the affinity of the compound with receptor. 
THP derivatives as inotropic and antiarrhythmic agents
3,4-Trans-4-aryl-3-(1-pyridino)-1,2,3,4-tetrahydropyridine-6-thiolates were synthesized by Krauze et al. by onepot condensation of an aromatic aldehyde, cyanothioacetamide, and n-acetylpyridinium chloride in the presence of piperidine. Upon evaluation of the effect on heart rate and force of contraction, no significant chronotropic activity was observed but they were active as inotropic agents. Compound 80 ( Figure 10 ) was the most active compound (EC 50 = 1.6 ± 0.7 µ M) as a positive inotropic agent and it contains a 3-nitroaryl group at position #4 of the 1,2,3,4-tetrahydropyridines. This compound showed a hypotensive effect at higher doses (1 mg/kg) as compared to the standard drug, milrinone (0.1 mg/kg), but it was not found to be toxic at higher doses (1000 mg/kg body weight). Therefore, compound 80 has the potential for further studies. 
THP derivatives as poly(ADP-ribose) polymerase-1 inhibitors
PARP-1 (poly(ADP-ribose) polymerase-1), which is a chromatin base nuclear enzyme, has an important role in genomic repair. 
Insecticidal activity of THPs
The design and synthesis of novel camptothecin analogues was carried out by Liu et 
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THPs having activity on dopamine receptors
Fused furo-and pyrano-tetrahydropyrido [2,3c] coumarin derivatives ( Figure 15 , compounds 100 and 101) were synthesized by Das et al. using a one-pot reaction of aromatic aldehyde, 3-aminocoumarin, and 3,4-dihydropyran by reflux in acetonitrile as a solvent. These compounds were evaluated for interaction with the dopamine D3 receptors of humans by molecular docking and some compounds showed excellent binding affinity with these receptors. The inhibition of dopamine D3 receptor is important for the treatment of schizophrenia, parkinsonism, and other neuropsychiatric disorders. 
THPs as GABA inhibitors and as GABA analogues
Synthesis of tetrahydropyridine-3-carboxylate derivatives was reported by Ramachandran et al. The method was used for the synthesis of biologically active 6-substituted and 5,6-disubstituted THPs. Compound 104 (Figure 16 ), for example, is the chiral analogue of the C-6 substituted guvacine derivative, which is a GABA uptake inhibitor. 95 Chiral 1,2,3,6-tetrahydropyridines-4-carboxylate derivatives were synthesized as analogues of isoguvacine. The reaction takes place between amino acid-derived aldehyde and ethyl acrylate by BaylisHillman reaction and ring closure metathesis in the presence of Grubbs second-generation catalyst was used to form the THP rings. 96 These compounds (105 and 106) are the pharmacophores of GABA inhibition. 95 They have the potential to be used as anticancer, antiviral, and antidiabetic agents. 104 NHeteroarylmethyl-5-hydroxy-1,2,5,6-tetrahydropyridine-3-carboxylic acid showed alpha glucosidase inhibitory activity. Structure-activity relationship studies showed that the presence of a carboxylic group at position #3, hydroxyl group at position #5, and heteroaromatic ring at position #1 is necessary for optimal activity.
The most potent (IC 50 = 2.34 µ M) alpha glucosidase inhibitor was compound 121. The derivatives in this series showed a reversible uncompetitive type of alpha glucosidase inhibition and have the potential for further modification. of lipophilic groups to this bicyclic system leads to the formation of active compounds. Compound 130 (IC 50 Aβ 42 = 84 nM, ligand lipophilicity efficiency = 3.6) is the most active compound, which contains trifluoromethyl and a chloro group attached to the phenyl ring ( Figure 19 ). Stereoseparation of this compound showed that the R -isomer was more potent (A β 42 = 60 nM) than the S -isomer. 112 Almorexant is a dual orexin receptor (OX 1 R and OX 2 R) antagonist that contains dimethoxy substituted tetrahydroisoquinoline. 113 Pyrazolo-tetrahydropyridine as a dual orexin receptor antagonist was reported by Sifferlen et al. based upon the activity of almorexant. The structure-activity relationship of the phenyl ethyl group showed that the methyl group or trifluoromethyl group at the para position of the aromatic ring produced potent compounds. In the case of disubstituted compounds, a methyl group at the para and meta position resulted in the formation of active compounds (hOX 1 R = 7 nM and hOX 2 R = 3 nM for 135). Similarly, compound 136, which contains a trifluoromethyl group at the para and fluorine atom at meta positions, was most active in this series (hOX 1 R = 5 nM and hOX 2 R = 4 nM). Compounds 135 and 136 also showed activity in an in vivo sleep model. 
Discussion
THP is a structural part of many synthetic pharmacologically active molecules as the main pharmacophore as well as a substituent. Monosubstituted THP derivatives were found to be inhibitors of some human enzymes like MAO and proteasome. Some monosubstituted THPs having long alkyl chains showed antifungal activity. Disubstituted THP derivatives such as 3-aryl and 4-aryl derivatives showed antiinflammatory activities and also inhibited the production of proinflammatory mediators such as TNF α and interleukin. Disubstituted THP having a 1-methyl group produced activities against muscarinic and nicotinic receptors while THP having a carbamyl or aryl group produced activity against glutamate, PPAR, and corticotropin-releasing receptors. Disubstituted THP derivatives have also shown some inhibitory effects on neurotransmitters such as GABA and serotonin. 1,2,5,6-Tetrahydropyridine derivatives attached to 1,2,5-thiadiazole, particularly the dimeric compounds, exhibited agonistic properties against muscarinic receptors and derivatives having the tetraethylene glycol spacer were selective for the M 1 and M 2 subtypes of muscarinic receptors. Other THP derivatives, 1-ethyl-4-phenyl-1,2,5,6-tetrahydropyridine-3 carboxylic acid esters, showed selectivity for M 5 receptors. The discovery of such derivatives is important for the production of compounds without producing adverse effects. Highly functionalized THP derivatives exhibited antibacterial, antifungal, antiplasmodial, antioxidant, antiinflammatory, analgesic, muscle relaxant, sedative, and anticancer activities. They have also presented activity as inotropic agents for the heart. Antibacterial activity of functionalized THP derivatives was more significant because they showed activity against different strains of pathogenic bacteria and some of them were also active against Mycobacterium, the causative agent of tuberculosis. THPs attached with additional aromatic and heteroaromatic rings such as imidazole-containing compounds were more prominent because they presented activity against multidrug-resistant strains of bacteria. 4-Phenyl substituted THP derivatives were found to inhibitors of the renin and PARP-1 enzymes. 4-Phenyl-1,2,3,6-tetrahydropyridine and 4-pyridyl-1,2,3,6-tetrahydropyridine attached with heterocyclic rings exhibited affinity for the 5-HT 1A receptors. 4-Phenyl-1,2,3,6-tetrahydropyridine, which contains halogen or some heterocyclic ring attached with a 4-phenyl group, showed more affinity for 5-HT 2c receptors. Condensed THPs such as tetrahydrothienopyridine derivatives showed antibacterial, anticancer, and antiinflammatory properties. Tetrahydroimidazopyridine and tetrahydroimidazoindenopyridine containing condensed THP derivatives have shown anti-HIV and insecticidal properties. Some of the condensed THP derivatives produced activities against dopamine and orexin human receptors and gamma secretase and tyrosine hydroxylase as enzyme inhibitors. THP is not a sole determinant of a particular pharmacological activity or selectivity for a particular target, but pharmacological activity is influenced by the nature and type of substituents attached to the THP. The synthesis of new THP derivatives, especially highly functionalized THP, has produced some interesting new molecules that will serve as leads for future drug discovery.
